Upload
oke
View
64
Download
1
Tags:
Embed Size (px)
DESCRIPTION
ENZYMES. Enzymes are proteins. Cofactors. Prostetic groups Metal ions Coenzymes. Covalent bond. Coordinative bond. Secondary interactions. Native conformation. Optimal Conditions :. pH. Ionic strength. Temperature. Solvent. Maximal catalytic activity. Active center:. Asp b COOH. - PowerPoint PPT Presentation
Citation preview
1
ENZYMESENZYMES
2
Enzymes are proteins
Enzymes are proteins
CofactorsCofactors
Prostetic groups
Metal ions
Coenzymes
Coordinative bond
Covalent bond
Secondary interactions
3
Optimal Conditions:
Ionic strength
Temperature
Solvent
pH
Native conformationNative conformation
Maximal catalytic activity
4
pH dependence of enzyme activitypH dependence of enzyme activity
Active center:
Glu COOH pKa = 5.9
-Lysozyme
Asp COOH pKa = 4.5
Optimal pH?
Example:
pH
4 5 6protonated deprotonated4.5 5.9
Asp - Glu
optimal pH Hw: Glu-, His+ (pKa 6.5)
5
pH
Enzymeactivity
5 64
pH profilespH profiles
pH optimum Isoelectric pont=
6
Temperature dependence of enzyme activityTemperature dependence of enzyme activity
T
Enzymeactivity
Heat denaturationchanges in conformation
Heat sensitivity is different
Heat-shock proteins
Q10 temperature coefficient
Optimal temperature
7
Calculation of enzyme activity:
Enzyme activity (EA) S]EA = t
P]EA = t
U (unit) U = mol/min
S.I. unit: Catal = mol/sec
substrate (S) product (P)
8
Turnover number(Molecular activity)
Carbonic anhydrase: 400 000/sec
mol (product)mol (enzyme) x sec
Chymotrypsin: 100/sec
Trp synthase: 2/sec
examples
9
G
Substrate (S) Product (P)
G
Eact
S ES*1 ES *
2 P ES* : enzyme-substrate complex
S
P
ES*1
ES*2
Enzymes as catalysts
Enzymes as catalysts
10
E.g.: „Stickase”
S PS*
E
ES*1
E
ES*2
11
Effect of enzymes :
The reaction mechanism changes
Activation energy decreases
G (Kes ) does not change
The equilibrium state
The time to reach the EQ decreases
Enzymes are catalizing directionsin both
does not change
12
The enzyme - substrate complex
The enzyme - substrate complex
Interactions:secondary bonds ionic bondscovalent bond (covalent catalysis)
Acid-base catalysis: proton shuttle
13
Enolase and 2-phospho-glycerate (2-PGA): ionic bond
2 Mg2+ cofactors
14
The enzyme-substrate complex (ES)
Enzymes are specific catalysts
Enzymes are specific catalysts
Lock and key model
E
S
„induced fit” model S
E
15
Hexokinase induced-fit
16
Hexokinase induced-fit
17
Entropy effect
Entropy effect
E
S1
S2
Binding of substrates• close in space• proper orientation
18
Dihydrofolate reductase
dihidrofolate
NADP+
cofaktor
19
Dihydrofolate reductase
dihidrofolate
NADP+
cofaktor
20
Medical-diagnostic significance of enzyme activity measurements
Medical-diagnostic significance of enzyme activity measurements
1. Non-functional plasma enzymes
accelerated death of certain tissues
soluble enzymes enter the circulation
21
Aminotransferases:a reversible exchange between an -amino and an -keto group
ALAT: alanine-amino transferase (or SGPT: serum glutamate - pyruvate aminotranspherase)
pyruvate alanine
glutamate -ketoglutarate
high ASAT in serum hepatocellular tissue destructione.g. in acute hepatitis (viral infection) in liver chirrosis in mononucleosis
22
ASAT:aspartate-amino transferase (or SGOT: serum glutamate -oxaloacetate aminotranspherase)
oxaloacetate aspartate
glutamate -ketoglutarate
high ALAT in serum muscle tissue destructione.g. in myocardial infarction in acute rheumatoid carditis in the first 10 days of heart surgery after heart massage after catheter treatment of heart
23
Creatine kinaseM: muscle form, B: brain form
MM, MB or BB izoenzymesMB form is found exclusively in the heart
creatine creatine-P
ATP ADP
high MB in serum myocardial diseasee.g. in myocardial infarction
(5-6 hrs after heart attack maximum value at 12 hrs)
colon cancer high MMrenal failure high MM
24
Medical-diagnostic significance of enzyme activity measurements
Medical-diagnostic significance of enzyme activity measurements
2. Functional plasma enzymes
25
LCAT:lecitine-cholesterol acyl transferase
free cholesterol cholesterol ester
lecitine lysolecitine
Deficiency: cholesterol cannot be transported in the blood
artheriosceloris, heart attack
26
Medical-diagnostic significance of enzyme activity measurements
Medical-diagnostic significance of enzyme activity measurements
3. Enzyme activity assay in tissue biopsy
27
Pyruvate carboxylase
pyruvate oxaloacetate
ATP, CO2ADP
Deficiency: mental retardation
Assay from skin biopsy
Treatment: oral Asp, Glu
28
Enzymes as Catalysts
Ser Proteases
Enzymes as Catalysts
Ser Proteases
29
Acid-Base CatalysisAcid-Base Catalysis
A general base
His
Cys-S -
Tyr-O -
Asp-, Glu -
A general acid
His+
Cys-SH
Tyr-OH
Lys+
30
Covalent CatalysisCovalent Catalysis
E + S [ES] E + P
Covalent bond in the enzyme-substrate complex
31
Ser ProteasesSer Proteases
Protease: cuts proteinshydrolysis of peptide bond
Ser-proteases: Ser in the active center
e.g.•Chymotrypsin•Trypsin•Ellastase•Thrombin•Other blood coagulation factors
32
DIPF: Specific inhibitor of Ser enzymesDIPF: Specific inhibitor of Ser enzymes
E
OHSer
O
P OF
ODi-isopropyl-fluoro-phosphate
Irreversibleinhibition
of Ser- enzymes
e.g. ChymotripsinAcetylcholinesterase(chemical weapon)
33
Proteolytic activation of zymogensProteolytic activation of zymogens
Intestine Pancreas
Trypsinogen
Chymotrypsinogen
- Chymotrypsin
Trypsin
Enteropeptidase
- Chymotrypsin
Trypsin inhibitorInactive trypsine
34
Interaction of 1NH3+
with 194Asp-
Chymotrypsinogen
15Arg
16Ile
H3N+
Trypsin
chymotrypsin (ACTIVE)
-chimotrypsin(ACTIVE)
Chymotrypsin
Formation of substrate binding pocket
Proteolytic activation of ChymotrypsinProteolytic activation of Chymotrypsin
35
Chymotrypsin: Acid-base catalysisThe catalytic triad
Chymotrypsin: Acid-base catalysisThe catalytic triad
57His
NHN
102 Asp195 Ser
HO
A proton shuttle in the active center
36
Chymotrypsin: Covalent catalysisChymotrypsin: Covalent catalysis
Peptide bond of the food protein
to be cut
O-
C
NH
O C
NH
1st tetrahedral transition intermedier
O
C H2N
1st product
Acyl-enzyme
intermedier+
Ser - OH
His
Ser - O
HisH+
Ser - O
His
37
+ H2O
O-
C OH 2nd tetrahedral transition intermedier
+O
C OH
2nd product
Ser - O
HisH+
Ser - OH
His
38
Specificity of Ser proteasesSpecificity of Ser proteases
O C
NH
CHR
Substrate binding pocket
Chymotrypsin: Big, nonpolar pocketR: aromatic rings (Phe, Tyr, Trp)
Trypsin: negatively charged pocketR: positive charges (Arg,Lys)
Elastase: small pocketR: small (Gly,Ala, Ser)
39
Thrombin is a Serine protease
Proteolytic cleveage (Xa)A
B
S
S
prothrombin
OH
thrombin
fibrinogen
fibrin
40
Enzyme KineticsEnzyme Kinetics
41
S Pv1
v -1
Conditions for measuring initial rate:
[P] 0v1 >>> v -11.
2. [S] 0
Enzyme activity (v) should be measured as initial rate:Enzyme activity (v) should be measured as initial rate:
42
S P[S] decreases[P] increases
S P
equilibrium
[P]
time
Initial rate
S Plinearity
v = constant v decreases v = 0
Product formation as the function of the timeProduct formation as the function of the time
43
The Michaelis-Menten modelThe Michaelis-Menten model
Assumptions:
E + S
k1
k - 1
[ES] E + Pk2
k -2 0IRREVERSIBLE
steadystate
[S] [ES]
One-substrate reaction
Initial rate
44
E + S
k1
k - 1
[ES] E + Pk2
Rate of [ES] formation= Rate of [ES] breakdown
steadystate
Definition: (k2+k-1)/k1= KM
v =vmax [S]
KM + [S]
45
v
[S]
vmax
vmax
12
KM
Vmax = max EA
KM = [S]where v = 1/2 vmax
I. Low [S] II. [S] = KM III. High [S]
Enzyme activity (v, initial rates) as the function of substrate concentration
Enzyme activity (v, initial rates) as the function of substrate concentration
46
v =vmax [S]
KM + [S]v =
vmax
KM
[S]
First order reactionI. Low [S]
II. [S] = KM
Michaelis-Menten Kinetics
III. High [S]
v =vmax [S]
KM + [S]
v = vmax
saturated substrate concentration
Zero order reaction
47
Turnover number kcat =Vmax
[E]
kcat
KM =k-1 + k2
k1
Affinity of the substrate to the enzymelow KM - high affinity
KM Michaelis constant
kcat
KM„catalytic efficiency”
48
Linearization for determination of KM and vmaxLinearization for determination of KM and vmax
1/v
1/[S]
- 1/KM
1/vmax
Lineweaver-Burkdouble reciprocal plot
Slope : Km/Vmax
49
[S] 200 20 2 0.2 0.15 0.013
v 60 60 60 48 45 12
9.1.2.1. Calculate the KM and the vmax from the data below!
v =vmax [S]
KM + [S]
Vmax = 60
12 = 60*0.013
KM + 0.013
Vmax/2=30
KM
50
[S] 200 20 2 0.2 0.15 0.013
v 60 60 60 48 45 12
9.1.2.1. Calculate the Vmax and KM using a graph!
Calculate the reciprocal values!
1/[S] 1/200 and so on
1/v 1/60 and so on
1/v
1/[S]
- 1/KM
1/vmax
1/v
1/[S]
1/v
1/[S]
- 1/KM- 1/KM
1/vmax1/vmax
1/v
1/[S]
- 1/KM
1/vmax
1/v
1/[S]
1/v
1/[S]
- 1/KM- 1/KM
1/vmax1/vmax
51
v= 60*0.1
0.05 + 0.1
Calculate the rate (v) at 0.1 mM and at 100 mM of S,if KM= 0.05 mM, vmax= 60 U
0.1 mM
100 mM v= 60*100
0.05 + 100
v =vmax [S]
KM + [S]v =
vmax [S]
KM + [S]
= 6
0.15= 40 U
= 6000
100.05= 60 U =vmax
52
v= 37*0.2* KM
KM + 0.2* KM
9.1.2.3. Calculate the rate (v) at [S] = 0.2 KM, if the Vmax is 37 U
v =vmax [S]
KM + [S]v =
vmax [S]
KM + [S]
= 37*0.2
1.2= 6.2 U
53
At which [S] will the enzyme show one-quarter of its maximal rate, if its KM=5 mM
v =vmax [S]
KM + [S]v =
vmax [S]
KM + [S]
Vmax/4=Vmax [S]
KM + [S]
(KM + [S]) =4 [S]
Here: [S] = 0.005/3
[S] = KM/(4-1)
54
Classification of enzymes
Classification of enzymes
1. Oxidoreductases
2. Transferases
3. Lyases
4. Isomerases
5. Ligases
55
Nomenclature based on the coenzymes
Nomenclature based on the coenzymes
ATP: kinase
e.g. glucose + ATP glucose-6-P + ADP
glucokinase (hexokinase)
NAD+/NADP+/FAD: dehydrogenase
e.g. lactate + NAD+ pyruvate + NADH + H+
lactate dehydrogenase
56
Phosphatase
Glucose -6P Glucose + Pi
Glucose-6-phosphatase
Phosphorylase
glycogen Glucose -1P+ Pi
Glycogen phosphorylase
57
ISOMERASE / MUTASE / EPIMERASE
Glucose -6Paldohexose
Fructose-6Pketohexose
Phosphohexose isomerase
3-P-glycerate 2-P-glyceratephosphoglycerate mutase
Mannose-5P Glucose-5P2- epimerase
Isomerase: interconversion of an aldo and a ketosugar
Mutase: alters the position of a group
Epimerase: rotates the assimetrical OH group
58
Enzyme Kinetics
Reversible Inhibitions
Enzyme Kinetics
Reversible Inhibitions
59
v
[S]
Competitive InhibitionCompetitive Inhibition
E
E
E
E + S ES E + P
E + I EI
Inhibitor: a substrate analogue binds to the same place
Substrate excess: no inhibition
vmax
12
KM KI
vmax
vmax: No change
KM: increases
60
CH3-CH2-OH CH3-CO
Halcohol
Alcohol dehydrogenase
Etylene glycol
CH2-OH
CH2-OH
CH2-CO
H
CH2-OHoxalate
Methanol/ethylene glycol poisoning:
CH3-OH H- CO
Hmethanol POISON
i.v. alcohol
61
E
E
E
[ES] E + P
[EI]
Noncompetitive InhibitionNoncompetitive Inhibition
[ESI]
E
v
[S]
vmax
12
KM
vmax
vmax: decreases
KM: No change
62
Linearization for determination of KM and vmaxLinearization for determination of KM and vmax
1/v
1/[S]
- 1/KM
1/vmax
Lineweaver-Burkdouble reciprocal plot
Comp. Inh.
Noncomp. Inh.
63
Un-competitive inhibitionUn-competitive inhibition
vmax: decreases
KM: decreases
The inhibitor binds only to the ES complex
[ES]
[ESI]
E
1/v
1/[S]
E E E + P
64
A competitive inhibitor increases/decreases/ does not change the KM of the enzyme
A noncompetitive inhibitor increases/decreases/ does not change the vmax of the enzyme
In case of un-competitive inhibition the inhibitorcan/cannot bind to the enzyme-substrate complex
65
Irreversible inhibitors
Poisons
Irreversible inhibitors
Poisons
66
Irreversible inhibitors of the enzymesIrreversible inhibitors of the enzymes
Specific reaction with the active center (covalent bond)-SH enzymes: monoiodoacetate-OH enzymes: DIPF (see Ser proteases)
Nonspecific inhibitors - denaturation of enzymes - Heavy metal ions- Heat
67
Regulation of enzyme activity
Allosteric regulation
Regulation of enzyme activity
Allosteric regulation
68
E
Apparent competitive inhibitionApparent competitive inhibition
E
E
E + S ES E + P
E + I EI
Inhibitor: NOT a substrate analogueALLLOSTERIC binding siteconformational change
Kinetics: competitive inhibition
69
Allosteric regulationAllosteric regulation
1. Substrate binding site2. Allosteric effector binding site
activator inhibitor
Changes in the conformation
Allosteric enzymes:
70
Conformation change of the enzyme
Decreases(apparent competitive inhibition)
increases
K-type enzymes KM
increases decreases
V-type enzymes Vmax
activation inactivation
71
4
v
[S]
v
[S]
Which of the following graphs shows the kinetics of an allosteric inhibition?
v
[S]
v
[S]
1 2
3
No effectoreffector
72
Allosteric regulationFeed back inhibition of the first specific (irreversible) step
of a pathway
Allosteric regulationFeed back inhibition of the first specific (irreversible) step
of a pathway
A
B C
D
Regulatory role of product “D”
INHIBITION
ACTIVATION
E
F
73
Medication of Hypercholesterolemia
Medication of Hypercholesterolemia
Statins(Mevastatin, Lovastatin)
Competitive analogues of the mevalonate
HMGCoA
cholesterol
REG. step
feed back
mevalonate
Cholesterol metabolism
Reversible inhibitorsMedical applications
Reversible inhibitorsMedical applications
74
Chemotherapy, Antitumor agentsChemotherapy, Antitumor agents
Nucleoside analogues: competitive inhibitors
AIDS - dideoxi nucleosidesColon cancer - 5-fluorouracilleukemia - arabinosyl cytosinesee: selected structures
Folic acid (vitamin) dihydrofolate tetrahydrofolate METOTREXATES solid tumors
Deoxynucleotide synthesis - Dihydrofolate reductase
DNA polymerase, substrates: nucleotides
75
Regulation of enzyme activityEnzyme induction
Regulation of enzyme activityEnzyme induction
cellHormone
nucleusDNA
geneenzyme
Hormone responsive
element
Transcription factor
New synthesis of proteins
76
Regulation of enzyme activityby enzyme induction/repression
Regulation of enzyme activityby enzyme induction/repression
Enzyme (protein)
Amino acids
Protein synthesis breakdown
Inducers: stimulate enzyme synthesisRepressors: enzyme synthesis is inhibited
Protein turnover
77
Regulation of enzyme activityby compartmentation
Regulation of enzyme activityby compartmentation
MitochondrionNADH production
oxidation of NADH: electrontransport chain
CytosolNADH
Lactate production
78
Regulation of enzyme activityby irreversible covalent modification
Regulation of enzyme activityby irreversible covalent modification
Proteolysis: Irreversible activation of proteases
E.g. Serine proteasespancreatic enzymesblood coagulation factors
79
9.1.2.5. [S] mM 0.05 0.067 0.1 0.13 0.27 0.53mU, no inhib. 0.40 0.50 0.60 0.66 0.80 0.88mU, with inhib. 0.17 0.20 0.24 0.27 0.32 0.36
0.60 = Vmax*0.1
KM + 0.1
0.50 = Vmax*0.067
KM + 0.067
no inhib.
0.24 = Vmax*0.1
KM + 0.1
0.20 = Vmax*0.067
KM + 0.067
with inhib.
Calculations, 9.1.2.5.
80REG
catalyticsubunits
REG
REG
Regulation of enzyme activity: Allosteric regulation - Cooperativity
Regulation of enzyme activity: Allosteric regulation - Cooperativity
81
Homotrop cooperativityHomotrop cooperativity
The catalitic subunit binds the substrate
this will activate the other catalitic subunits
substrate = activatorsubunits are equal
TT formhigh KM
+S
low KM
RR form
+S
RR form
T: less active( „tense” form)
R: more active (relaxed form)
82
Kooperativity: sigmoid graph
Kooperativity: sigmoid graph
v
[S]The enzyme works in a narrow concentration range
KM increases
Aspartate transcarbamoylase:Homotrop cooperativity
Aspartate transcarbamoylase:Homotrop cooperativity
Interaction of 6 catalytic subunits:s s s
T forms
S S S
R forms
83
Heterotrop cooperativityHeterotrop cooperativity
The regulatory subunit binds the allosteric effector
activates/inactivates the catalitic subunits
substrate = activatorsubunits are different
More active
+I
I
I
Less active
84
Aspartate transcarbamoylase: 6 regulatory subunitsPositive (ATP) and negative (CTP) heterotrop effect
Aspartate transcarbamoylase: 6 regulatory subunitsPositive (ATP) and negative (CTP) heterotrop effect
Sigmoid graph (cooperativity)
v
[S]
ATP+CTP-
Activator(ATP): less sigmoid
Inhibitor(CTP): more sigmoid graph
lower KM
higher KM
-
Feed back inhibition
Pathway
CTP
Asp + carbamoyl-P
ATP +
85
PathwayGlc
PFK
Dual role of ATP: Substrate AND inhibitore.g. phosphofructokinase (PFK)
Dual role of ATP: Substrate AND inhibitore.g. phosphofructokinase (PFK)
ATP (energy)
-
Feed back inhibition of the product
+ATP
v
[ATP]
86
• The same reaction is catalyzed
• Differences– Distribution among organs– Different genes– quantitative parameters (v; KM)– substrate specificity– regulation
IsoenzymesIsoenzymes
87
Isoenzymes: e.g. glucokinase/hexokinase
Isoenzymes: e.g. glucokinase/hexokinase
v
[glucose]KMKM
hexokinase
glucokinase
KM = 0.5 mM
KM = 10 mM
high affinity
low affinity
88
Different KM - different phase of working activity
GUT Hyperglycaemiaafter meal
liver
glucokinase
RBChexokinase
Glc utilizationat normal/low level
Glc utilizationonly at high level
89
At which [S] will glucokinase show one-quarter of its maximal rate, if its KM=10 mM
v =vmax [S]
KM + [S]v =
vmax [S]
KM + [S]
Vmax/4=Vmax [S]
KM + [S]
[S] = 3.3 mM
1
4=
[S]
10 + [S]
90
Isoenzymes: Lactate dehydrogenaseIsoenzymes: Lactate dehydrogenase
CO O–
C
CH3
O
CO O–
C
CH3
HHO
NADH + H+
NAD+
pyruvate lactate
4 subunits (two types: H and M)
5 izoenzymes: H4 H3M H2M2 HM3 M4
Characteristic tissue distribution: H4: heartM4: liver, HxMx: muscle
Nonfunctional plasma enzymestissue damage: appearance in the serum diagnosis
91
Regulation of enzyme activity: Hormonal regulation
Regulation of enzyme activity: Hormonal regulation
Covalent modification:
Enzyme phosphorylation / dephosphorylation
CHANGES IN THE CONFORMATION
Activation / inactivation
92
Mechanism of enzyme phosphorylationMechanism of enzyme phosphorylation
+ ATP E
P
+ ADP
Dephosphorylated enzyme Phosphorylated enzyme
E
Ser - O - P OO -
O -
Covalent bond (ester bond)
Protein kinase A (PK A)(cAMP dependent)
E
Phosphorylation site
93
cAMP is an ancient signal of hungercAMP is an ancient signal of hunger
Blood
glucagon(hormon)
hypo-glycaemia(starvation)
LIVER CELL
ATP
cAMP
AC: adenylate cyclase
AC
E
P
HR
R: hormon receptor
Starvation:all enzymes phosphorylated(activated or inactivated)
PK A
E
94
Phosphorylated enzymes can be either activated or inactivated
Phosphorylated enzymes can be either activated or inactivated
Blood
low glc
glucagon
LIVER produces glc from glycogen
glycogen
P inactive
P active
95
Well fed state: insulinWell fed state: insulin
Blood
hyper-glycaemia
insulin(hormon)
LIVER CELL
E
P
HR
R: hormon receptor
Well fed:all enzymes dephosphorylated(activated or inactivated)
protein phosphatase
PiE
96
Blood
high glc
insulin
LIVER produces glycogen from glc
glycogen
active
inactive
97
Regulation of enzyme activity
Complex regulation(allosteric + hormonal)
Regulation of enzyme activity
Complex regulation(allosteric + hormonal)
98
Phosphorylase kinasePactive
EpinephrineHormonal regulation
STRESS Muscle contraction
Ca2+
Glycogen phosphorylase
ATP glycogen
EnergyP active
Muscle: glycogen breakdown in exerciseMuscle: glycogen breakdown in exercise
99
: catalitic subunit
partially active
-PP-
FULLY ACTIVE
-PP-
Ca2+
Ca2+
epinephrine
inactive
Ca2+PK A
: regulatory subunits, phosphorylation site
Ca2+
glycogen
EnergyP active
Phosphorylase kinase
Muscle contraction
Ca2+
EpinephrineHormonal regulation
STRESS
Pactive
Complex regulation of phosphorylase kinaseComplex regulation of phosphorylase kinase
(calmoduline): regulatory subunit, Ca2+ binding site
100
glycogen
EnergyP active
Phosphorylase kinase
Muscle contraction
Ca2+
EpinephrineHormonal regulation
STRESS
Pactive
Glycogen phosphorylase
ATP Complex regulation of Glycogen phosphorylaseComplex regulation of Glycogen phosphorylase
TT
ATP glucose
RRPP
TTPP
Phosphorylase kinase
101
glycogen
EnergyP active
Phosphorylase kinase
Muscle contraction
Ca2+
EpinephrineHormonal regulation
STRESS
Pactive
Glycogen phosphorylase
ATP
PFK I
ATP
PFK I : Dual role of ATPPFK I : Dual role of ATP
E
Phosphofructokinase
active center
Fructose-6-P
ATP
Allosteric site
EATP
Higher KM
102
Regulation of Enzyme Activity Summary
Regulation of Enzyme Activity Summary
1. Allosteric regulation - intracellular - fastmain effectors: ATP/ADP, NAD+/NADH, end products
2. Hormonal regulation - slower Enzyme phosphorylation/dephosphorylation
activation or inactivation
3. Enzyme induction - new enzyme synthesis - slowestinduction of gene expression (hormonal effect)
4. Irreversible activation by proteolysis